DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Lirilumab is an investigational drug.
There have been 12 clinical trials for Lirilumab. The most recent clinical trial was a Phase 1 trial, which was initiated on March 1st 2016.
The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are Bristol-Myers Squibb, M.D. Anderson Cancer Center, and Innate Pharma.
There are five US patents protecting this investigational drug and fifty-five international patents.
Recent Clinical Trials for Lirilumab
|Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer||Bristol-Myers Squibb||Phase 1|
|Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer||PrECOG, LLC.||Phase 1|
|Adjuvant Nivolumab and Lirilumab in Patients With Relapsed, Resectable Squamous Cell Carcinoma of the Head and Neck||Bristol-Myers Squibb||Phase 2|
Top disease conditions for Lirilumab
Top clinical trial sponsors for Lirilumab
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Lirilumab||See Pricing||Methods and compositions for treating conditions associated with an abnormal inflammatory responses||First Wave Bio, Inc. (Ann Arbor, MI)||See Pricing|
|Lirilumab||See Pricing||Cholestosome vesicles for incorporation of molecules into chylomicrons||THERASYN SENSORS, INC. (Eggertsville, NY)||See Pricing|
|Lirilumab||See Pricing||Disease therapy by inducing immune response to Trop-2 expressing cells||IBC Pharmaceuticals, Inc. (Morris Plains, NJ)||See Pricing|
|Lirilumab||See Pricing||LPT-723 and immune checkpoint inhibitor combinations and methods of treatment||Biomed Valley Discoveries, Inc. (Kansas City, MO)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|